11 Jan 2019 Governance

Leukaemia UK and Leuka have merged

We are delighted to announce that on 1 November Leuka and Leukaemia UK merged, bringing together two of the UK’s leading leukaemia and blood cancer charities to create one charity dedicated to innovative research and care for people affected by blood cancers. The two charities have joined forces under the name Leukaemia UK, uniting Leuka’s 37 years’ experience in ground-breaking medical research with Leukaemia UK’s four decades of pioneering care.

From research to care, the new charity will continue to put people affected by blood cancers at its heart. Together, Leukaemia UK aims to carry out even more world-class research and advances in care.

Leukaemia UK will be led jointly by Leuka’s CEO Olive Boles and Leukaemia UK’s CEO Angela Smith-Morgan. The charity’s new Chair of Trustees is Chris Corbin, current Chair of Leuka, who is supported by a Board including both Leuka and Leukaemia UK Trustees.

Related posts

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

19 February 2024

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

Leukaemia UK is delighted to launch a brand-new funding scheme in 2024, intended specifically for innovative, patient-focussed applied research and targeting UK-based healthcare professionals.   The first of its kind for…

Cancer charities unite in encouraging the Government to address crucial issues as part of their “War on Cancer”

4 July 2022

Cancer charities unite in encouraging the Government to address crucial issues as part of their “War on Cancer”

In collaboration with our partners and as part of the One Cancer Voice group, Cancer 52 and Blood Cancer Alliance, we have called on the Government to take account of a wide range of recommendations as they finalise the 10-Year Cancer Plan to be announced later this year.

University of Southampton’s Dr Giorgia Chiodin Wins Olive Boles Innovation Award

7 November 2024

University of Southampton’s Dr Giorgia Chiodin Wins Olive Boles Innovation Award

Dr Giorgia Chiodin from the University of Southampton has been awarded the prestigious Olive Boles Innovation Award for 2024. Awarded annually to a Leukaemia UK John Goldman Fellow, this award…

Family ‘devastated’ by leukaemia after double diagnosis say ‘so much more needs to be done’

8 December 2023

Family ‘devastated’ by leukaemia after double diagnosis say ‘so much more needs to be done’

57-year-old Hampshire resident Karen Cracknell is supporting Leukaemia UK’s appeal for funds this Christmas, having experienced the ‘devastating impact’ after both her mother and father were diagnosed with blood cancer.  …